Companies / Maplight Therapeutics Inc

Maplight Therapeutics Inc

Nasdaq: MPLTCIK 1770069REDWOOD CITY, CA

Financials

Revenue—
Net income$-161.15M
Total debt—
Cash$71.63M
Diluted EPS$-18.56
Shares outstanding45.3M

Ownership

45.3M shares outstanding · as of May 7, 2026
6.2%Insiders
Ownership
94.0%Common Stock
Share classes
Common Stock93.99%
Common Stock6.01%
Insiders6.20%2,813,318
10%+ / strategic6.17%2,799,180
Institutions46.85%21,244,544
Public float40.77%18,488,634

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Kroeger Christopher A.CEOChief Executive Officer · Director
3.64%1,649,751
Foff Erin PennockChief Medical Officer
0.89%403,835
Setia VishwasChief Financial Officer
0.87%395,549
Malenka Robert C.Director
0.72%325,059
Lillie James WoodruffFormerChief Scientific Officer
0.66%298,862
Kreitzer AnatolFormerChief Discovery Officer
0.57%259,928
Gillis JonathanFormerCAAO and PAO
0.56%254,523
Hanson KristopherFormerGeneral Counsel
0.42%191,582
Pavlov GeorgeDirector
0.06%25,000
Garnett Timothy JohnDirector
0.03%14,124

Institutional holders 81

View all →
HolderValue% of shares
Novo Holdings A/S$74.95M8.13%
Fcpm III Services B.V.$56.67M7.12%
BlackRock, Inc.$36.74M2.26%
The Goldman Sachs Group, Inc.$34.03M4.27%
State Street Corporation$30.54M1.88%
Sanofi$18.54M2.01%
Nan Fung Group Holdings Ltd$17.06M2.14%
5AM Venture Management, LLC$16.69M2.10%
Vanguard Group Inc$15.28M1.92%
Pivotal bioVenture Partners Investment Advisor LLC$10.74M1.35%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 27, 2026Kroeger Christopher A.
CEO
OtherVoting Common Stock$3.67M-204K
-11.15%
1,626,606
3.59% of shares
low
Jan 27, 2026Lillie James Woodruff
Executive
OtherVoting Common Stock$810.1K-45K
-13.40%
291,132
0.64% of shares
low
Jan 27, 2026Foff Erin Pennock
Executive
OtherVoting Common Stock$802.2K-45K
-10.25%
390,475
0.86% of shares
low
Jan 27, 2026Kreitzer Anatol
Executive
OtherVoting Common Stock$756.9K-42K
-14.22%
253,908
0.56% of shares
low
Jan 27, 2026Setia Vishwas
Executive
OtherVoting Common Stock$600.2K-33K
-7.93%
387,819
0.86% of shares
low
Jan 27, 2026Hanson Kristopher
Executive
OtherVoting Common Stock$467.6K-26K
-12.39%
183,852
0.41% of shares
low
Jan 27, 2026Gillis Jonathan
Executive
OtherVoting Common Stock$396.5K-22K
-8.15%
248,503
0.55% of shares
low
Jan 29, 2026Malenka Robert C.
Director
SellVoting Common Stock$394.4K-21K
-5.41%
371,885
0.82% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Forbion Growth Opportunities Fund III Cooperatief U.A.Passive13G———
T. Rowe Price Investment Management, Inc.Passive13G—2,799,180—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MPLTCommon StockEquity56565P103BBG01JZ5DBQ0